Palmitic Acid Inhibits Cell Proliferation and Tumor Growth of Endometrial Cancer In Vitro and In Vivo
Authors:
- Ziyi ZhaoZZZiyi Zhao
- Jiandong WangJWJiandong Wang
- Weimin KongWKWeimin Kong
- Meredith Anne NewtonMNMeredith Anne Newton
- Wesley BurkettWBWesley Burkett
- Wenchuan SunWSWenchuan Sun
- Lindsey BuckinghamLBLindsey Buckingham
- Jillian DonnellJDJillian Donnell
- Hongyan SuoHSHongyan Suo
- Boer DengBDBoer Deng
- Xiaochang ShenXSXiaochang Shen
- Xin ZhangXZXin Zhang
Preprint
- 31 January 2024
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Epidemiological and clinical evidence have extensively documented the role of obesity in the develop-ment of endometrial cancer. However, the effect of fatty acids on cell growth in endometrial cancer has not been widely studied. Here we reported that palmitic acid significantly inhibited cell proliferation of endometrial cancer cells and primary cultures of endometrial cancer, and reduced tumor growth in a transgenic mouse model of endometrial cancer, in parallel with increased cellular stress and apoptosis and decreased cellular adhesion and invasion. Inhibition of cellular stress by N-acetyl-L-cysteine effec-tively reversed the effects of palmitic acid on cell proliferation, apoptosis and invasive capacity in the endometrial cancer cells. Palmitic acid increased the intracellular formation of lipid droplets in a time- and dose-dependent manner. Depletion of lipid droplets by blocking DGAT1 and DGAT2 effectively increased the ability of palmitic acid to inhibit cell proliferation and induce cleaved caspase 3 activity. Collectively, this study provides new insight into the effect of palmitic acid on cell proliferation, inva-sion and the formation of lipid droplets that may have potential clinical relevance in the treatment of obesity-driven endometrial cancerKeywords
All Related Versions
This publication has 70 references indexed in Scilit:
- Activation of SREBP-1c alters lipogenesis and promotes tumor growth and metastasis in gastric cancerBiomedicine & Pharmacotherapy, 2020
- Ceramide and palmitic acid inhibit macrophage-mediated epithelial–mesenchymal transition in colorectal cancerMolecular and Cellular Biochemistry, 2020
- Palmitic acid is an intracellular signaling molecule involved in disease developmentCellular and Molecular Life Sciences, 2019
- Stimulating effect of palmitate and insulin on cell migration and proliferation in PNT1A and PC3 prostate cells: Counteracting role of metforminThe Prostate, 2018
- Acute hypoxic preconditioning prevents palmitic acid‐induced cardiomyocyte apoptosis via switching metabolic GLUT4‐glucose pathway back to CD36‐fatty acid dependentJournal of Cellular Biochemistry, 2017
- Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4/ROS/NF-κB/MMP-9 signaling pathwayBiochemical and Biophysical Research Communications, 2017
- Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolismHepatology, 2017
- Single-cell time-of-flight secondary ion mass spectrometry reveals that human breast cancer stem cells have significantly lower content of palmitoleic acid compared to their counterpart non-stem cancer cellsBiochimie, 2014
- Therapeutic Strategies for Metabolic Diseases: Small‐Molecule Diacylglycerol Acyltransferase (DGAT) InhibitorsChemMedChem, 2014
- The EMT signaling pathways in endometrial carcinomaClinical and Translational Oncology, 2012